JP2012502010A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012502010A5 JP2012502010A5 JP2011525573A JP2011525573A JP2012502010A5 JP 2012502010 A5 JP2012502010 A5 JP 2012502010A5 JP 2011525573 A JP2011525573 A JP 2011525573A JP 2011525573 A JP2011525573 A JP 2011525573A JP 2012502010 A5 JP2012502010 A5 JP 2012502010A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- hydrogen
- independently
- membered
- different
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08163897 | 2008-09-08 | ||
| EP08163897.5 | 2008-09-08 | ||
| PCT/EP2009/061656 WO2010026262A1 (en) | 2008-09-08 | 2009-09-08 | Pyrido [5, 4-d] pyrimidines as cell proliferation inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012502010A JP2012502010A (ja) | 2012-01-26 |
| JP2012502010A5 true JP2012502010A5 (enExample) | 2012-10-18 |
| JP5576379B2 JP5576379B2 (ja) | 2014-08-20 |
Family
ID=40297852
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011525573A Active JP5576379B2 (ja) | 2008-09-08 | 2009-09-08 | 細胞増殖阻害剤としてのピリド［５，４−ｄ］ピリミジン |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8653087B2 (enExample) |
| EP (1) | EP2350083B1 (enExample) |
| JP (1) | JP5576379B2 (enExample) |
| KR (1) | KR20110063528A (enExample) |
| CN (1) | CN102203098A (enExample) |
| AR (1) | AR073501A1 (enExample) |
| AU (1) | AU2009289196A1 (enExample) |
| CA (1) | CA2736306A1 (enExample) |
| CL (1) | CL2011000489A1 (enExample) |
| IL (1) | IL211136A0 (enExample) |
| MX (1) | MX2011002431A (enExample) |
| NZ (1) | NZ591493A (enExample) |
| RU (1) | RU2011113402A (enExample) |
| TW (1) | TW201014860A (enExample) |
| WO (1) | WO2010026262A1 (enExample) |
| ZA (1) | ZA201101090B (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CL2008001943A1 (es) * | 2007-07-02 | 2009-09-11 | Boehringer Ingelheim Int | Compuestos derivados de fenil-triazol, inhibidores de enzimas de señales especificas que participan del control de la proliferacion celular; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer, infecciones, enfermedades inflamatorias y autoinmunes. |
| TW201014860A (en) | 2008-09-08 | 2010-04-16 | Boehringer Ingelheim Int | New chemical compounds |
| EP2350052B1 (en) | 2008-09-29 | 2014-08-13 | Boehringer Ingelheim International GmbH | Antiproliferative compounds |
| EP2398797B1 (en) * | 2009-02-17 | 2013-11-06 | Boehringer Ingelheim International GmbH | Pyrimido[5,4-d]pyrimidine derivatives for the inhibition of tyrosine kinases |
| CN105853415A (zh) | 2009-05-12 | 2016-08-17 | 罗马克实验室有限公司 | 卤代烷基杂芳基苯甲酰胺化合物 |
| BRPI1014322A2 (pt) | 2009-06-26 | 2015-08-25 | Romark Lab Lc | Método para tratar infecção, e para interromper ou evitar a produção de partículas virais infecciosas, combinação, e, composição farmacêutica. |
| EP2552907B1 (en) | 2010-03-26 | 2014-10-22 | Boehringer Ingelheim International GmbH | Pyridyltriazoles |
| US9290507B2 (en) | 2010-03-26 | 2016-03-22 | Boehringer Ingelheim International Gmbh | B-RAF kinase inhibitors |
| US8710055B2 (en) | 2010-12-21 | 2014-04-29 | Boehringer Ingelheim International Gmbh | Triazolylphenyl sulfonamides as serine/threonine kinase inhibitors |
| JP6165733B2 (ja) | 2011-09-16 | 2017-07-19 | ノバルティス アーゲー | Ｎ−置換ヘテロシクリルカルボキサミド類 |
| IN2014DN07954A (enExample) | 2012-03-13 | 2015-05-01 | Basf Se | |
| CA2923101A1 (en) | 2013-09-16 | 2015-03-19 | Basf Se | Fungicidal pyrimidine compounds |
| WO2015036059A1 (en) | 2013-09-16 | 2015-03-19 | Basf Se | Fungicidal pyrimidine compounds |
| EP3609882B1 (en) | 2017-03-17 | 2022-07-13 | Cardio Therapeutics Pty Ltd | Heterocyclic inhibitors of pcsk9 |
| TW202309022A (zh) | 2021-04-13 | 2023-03-01 | 美商努法倫特公司 | 用於治療具egfr突變之癌症之胺基取代雜環 |
| CA3215668C (en) * | 2021-04-19 | 2025-05-20 | Universite De Montreal | PYRIDO[3,2-D]PYRIMIDINE COMPOUNDS, COMPOSITIONS CONTAINING THEM AND RELATED USES |
| AU2022260863B2 (en) * | 2021-04-19 | 2025-06-19 | Universite De Montreal | Pyrimido[5,4,d]pyrimidine compounds, compositions comprising them and uses thereof |
| JP2025535134A (ja) * | 2022-10-13 | 2025-10-22 | ユニヴェルシテ ド モントリオール | チアゾロ［５，４－ｄ］ピリミジン化合物、該化合物を含む組成物、及びそれらの使用方法 |
| AU2023410324A1 (en) | 2022-12-22 | 2025-05-15 | Boehringer Ingelheim International Gmbh | Crystalline forms of a her2 inhibitor |
| CN121568696A (zh) | 2023-07-28 | 2026-02-24 | 勃林格殷格翰国际有限公司 | 制备her2抑制剂的方法 |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL112249A (en) * | 1994-01-25 | 2001-11-25 | Warner Lambert Co | Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds |
| TW414798B (en) * | 1994-09-07 | 2000-12-11 | Thomae Gmbh Dr K | Pyrimido (5,4-d) pyrimidines, medicaments comprising these compounds, their use and processes for their preparation |
| CA2223081C (en) * | 1995-06-07 | 2001-03-06 | Pfizer Inc. | Heterocyclic ring-fused pyrimidine derivatives |
| DE19608653A1 (de) | 1996-03-06 | 1997-09-11 | Thomae Gmbh Dr K | Pyrimido[5,4-d]pyrimidine, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
| DE19608588A1 (de) | 1996-03-06 | 1997-09-11 | Thomae Gmbh Dr K | Pyrimido [5,4-d]pyrimidine, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
| AR007855A1 (es) * | 1996-07-13 | 1999-11-24 | Glaxo Group Ltd | Compuestos heterociclicos fusionados como inhibidores de proteina tirosina quinasa, sus metodos de preparacion, intermediarios, uso en medicinay composiciones farmaceuticas que los contienen |
| US6391874B1 (en) | 1996-07-13 | 2002-05-21 | Smithkline Beecham Corporation | Fused heterocyclic compounds as protein tyrosine kinase inhibitors |
| EP0837063A1 (en) | 1996-10-17 | 1998-04-22 | Pfizer Inc. | 4-Aminoquinazoline derivatives |
| UA71945C2 (en) | 1999-01-27 | 2005-01-17 | Pfizer Prod Inc | Substituted bicyclic derivatives being used as anticancer agents |
| JP3270834B2 (ja) * | 1999-01-27 | 2002-04-02 | ファイザー・プロダクツ・インク | 抗がん剤として有用なヘテロ芳香族二環式誘導体 |
| DE19911510A1 (de) * | 1999-03-15 | 2000-09-21 | Boehringer Ingelheim Pharma | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
| ATE329909T1 (de) | 2002-11-27 | 2006-07-15 | Boehringer Ingelheim Pharma | 1,2,3-triazolamid-derivate als cytokininhibitoren |
| SG146624A1 (en) | 2003-09-11 | 2008-10-30 | Kemia Inc | Cytokine inhibitors |
| US7511042B2 (en) | 2003-12-03 | 2009-03-31 | Boehringer Ingelheim Pharmaceuticals, Inc. | Triazole compounds |
| DE102004002557A1 (de) * | 2004-01-17 | 2005-08-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung von substituierten Pyrimido(5,4-d)pyrimidinen zur Behandlung von Atemwegserkrankungen |
| EP1725544B1 (en) | 2004-03-09 | 2009-05-27 | Boehringer Ingelheim Pharmaceuticals Inc. | 3-[4-heterocyclyl-1,2,3-triazol-1-yl]-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases |
| US7485657B2 (en) | 2004-05-12 | 2009-02-03 | Boehringer Ingelheim Pharmaceuticals, Inc. | Anti-cytokine heterocyclic compounds |
| US7531560B2 (en) | 2004-11-10 | 2009-05-12 | Boehringer Ingelheim Pharmaceuticals, Inc. | Anti-cytokine heterocyclic compounds |
| JP2007076376A (ja) | 2005-09-09 | 2007-03-29 | Yanmar Co Ltd | トラクタ |
| WO2007056016A2 (en) | 2005-11-02 | 2007-05-18 | Kemia, Inc. | Bisamide cytokine inhibitors |
| WO2007075896A2 (en) | 2005-12-22 | 2007-07-05 | Kemia, Inc. | Heterocyclic cytokine inhibitors |
| JP2009536618A (ja) | 2006-04-18 | 2009-10-15 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ４−及び５−イミダゾリル環を含むサイトカイン阻害化合物の製造方法及びその中間体 |
| JP2009537520A (ja) * | 2006-05-15 | 2009-10-29 | アイアールエム・リミテッド・ライアビリティ・カンパニー | Ｆｇｆ受容体キナーゼ阻害剤のための組成物および方法 |
| PE20080401A1 (es) | 2006-07-07 | 2008-06-23 | Boehringer Ingelheim Int | DERIVADOS DE HETEROARIL-FENIL SUSTITUIDOS COMO INHIBIDORES DE B-Raf-QUINASAS |
| PE20080906A1 (es) | 2006-08-17 | 2008-07-05 | Kemia Inc | Derivados heteroarilo como inhibidores de citocina |
| WO2008089034A2 (en) | 2007-01-11 | 2008-07-24 | Kemia, Inc. | Cytokine inhibitors |
| US20100144764A1 (en) | 2007-04-13 | 2010-06-10 | Schering Corporation | Pyrimidinedione derivatives and methods of use thereof |
| CL2008001943A1 (es) | 2007-07-02 | 2009-09-11 | Boehringer Ingelheim Int | Compuestos derivados de fenil-triazol, inhibidores de enzimas de señales especificas que participan del control de la proliferacion celular; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer, infecciones, enfermedades inflamatorias y autoinmunes. |
| CA2692379A1 (en) | 2007-07-02 | 2009-01-08 | Boehringer Ingelheim International Gmbh | Antiproliferative compounds based on 5-membered heterocycles |
| JP2010533729A (ja) | 2007-07-17 | 2010-10-28 | プレキシコン，インコーポレーテッド | キナーゼ調節のための化合物と方法、及びそのための適応 |
| TW201014860A (en) | 2008-09-08 | 2010-04-16 | Boehringer Ingelheim Int | New chemical compounds |
| EP2350052B1 (en) | 2008-09-29 | 2014-08-13 | Boehringer Ingelheim International GmbH | Antiproliferative compounds |
| WO2010042337A1 (en) | 2008-10-07 | 2010-04-15 | Merck Sharp & Dohme Corp. | Novel 6-azaindole aminopyrimidine derivatives having nik inhibitory activity |
| EP2398797B1 (en) | 2009-02-17 | 2013-11-06 | Boehringer Ingelheim International GmbH | Pyrimido[5,4-d]pyrimidine derivatives for the inhibition of tyrosine kinases |
| US9290507B2 (en) | 2010-03-26 | 2016-03-22 | Boehringer Ingelheim International Gmbh | B-RAF kinase inhibitors |
| EP2552907B1 (en) | 2010-03-26 | 2014-10-22 | Boehringer Ingelheim International GmbH | Pyridyltriazoles |
| US8710055B2 (en) | 2010-12-21 | 2014-04-29 | Boehringer Ingelheim International Gmbh | Triazolylphenyl sulfonamides as serine/threonine kinase inhibitors |
| US20130023531A1 (en) | 2011-01-27 | 2013-01-24 | Boehringer Ingelheim International Gmbh | Pyrimido[5,4-d]pyrimidylamino phenyl sulfonamides as serine/threonine kinase inhibitors |
| US8889684B2 (en) | 2011-02-02 | 2014-11-18 | Boehringer Ingelheim International Gmbh | Azaindolylphenyl sulfonamides as serine/threonine kinase inhibitors |
-
2009
- 2009-09-07 TW TW098130118A patent/TW201014860A/zh unknown
- 2009-09-07 AR ARP090103435A patent/AR073501A1/es unknown
- 2009-09-08 RU RU2011113402/04A patent/RU2011113402A/ru not_active Application Discontinuation
- 2009-09-08 WO PCT/EP2009/061656 patent/WO2010026262A1/en not_active Ceased
- 2009-09-08 JP JP2011525573A patent/JP5576379B2/ja active Active
- 2009-09-08 KR KR1020117008042A patent/KR20110063528A/ko not_active Withdrawn
- 2009-09-08 AU AU2009289196A patent/AU2009289196A1/en not_active Abandoned
- 2009-09-08 NZ NZ591493A patent/NZ591493A/en not_active IP Right Cessation
- 2009-09-08 EP EP09782789.3A patent/EP2350083B1/en active Active
- 2009-09-08 US US13/062,058 patent/US8653087B2/en active Active
- 2009-09-08 CN CN2009801439757A patent/CN102203098A/zh active Pending
- 2009-09-08 MX MX2011002431A patent/MX2011002431A/es unknown
- 2009-09-08 CA CA2736306A patent/CA2736306A1/en not_active Abandoned
-
2011
- 2011-02-09 IL IL211136A patent/IL211136A0/en unknown
- 2011-02-10 ZA ZA2011/01090A patent/ZA201101090B/en unknown
- 2011-03-07 CL CL2011000489A patent/CL2011000489A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2011113402A (ru) | ПИРИДО[5,4d]ПИРИМИДИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ ПРОЛИФЕРАЦИИ КЛЕТОК | |
| JP2013532652A5 (enExample) | ||
| JP2008510770A5 (enExample) | ||
| JP2009535307A5 (enExample) | ||
| RU2012138892A (ru) | СОЛИ И ПОЛИМОРФЫ 8-ФТОР-2-{4-[(МЕТИЛАМИНО)МЕТИЛ]ФЕНИЛ}-1,3,4,5,-ТЕТРАГИДРО-6Н-АЗЕПИНО[5,4,3-cd]ИНДОЛ-6-ОНА | |
| JP2010515731A5 (enExample) | ||
| JP2021521104A5 (enExample) | ||
| JP2011516460A5 (enExample) | ||
| JP2011006480A5 (enExample) | ||
| WO2006095159A8 (en) | (imidazolo-5-yl)-2-anilo-pyrimidines as agents for the inhibition of cell proliferation | |
| JP2011526924A5 (enExample) | ||
| IL198115A (en) | The heteroaryl compounds, their vehicles, and their use in drug preparation | |
| JP2010511018A5 (enExample) | ||
| NZ595035A (en) | Substituted diazole and triazole compounds and compositions and methods of use | |
| JP2012524055A5 (enExample) | ||
| FI3568205T3 (fi) | Somatostatiinireseptoreita liikailmentävien syöpäsolujen hoito käyttämällä radioisotooppeihin kelatoituja okreotidijohdannaisia | |
| CA2565660A1 (en) | Ortho substituted aryl or heteroaryl amide compounds | |
| JP2019512535A5 (enExample) | ||
| JP2013526559A5 (enExample) | ||
| JP2007524707A5 (enExample) | ||
| JP2011529468A5 (enExample) | ||
| JP2012517986A5 (ja) | Ｂ−Ｒａｆキナーゼを阻害するためのピリミドピリミジン誘導体 | |
| JP2007533635A5 (enExample) | ||
| IL313466B1 (en) | Inhibiting creb binding protein (cbp) | |
| JP2018532786A5 (enExample) |